Gut-Brain Glucose Signaling in Energy Homeostasis, Cell Metab, vol.25, issue.6, pp.1231-1242, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339600
Renal gluconeogenesis: its importance in human glucose homeostasis, Diabetes Care, vol.24, issue.2, pp.382-391, 2001. ,
Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis, Am J Physiol Endocrinol Metab, vol.282, issue.2, pp.419-427, 2002. ,
Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin, Endocrinology, vol.150, issue.2, pp.616-624, 2009. ,
Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes, Am J Physiol Endocrinol Metab, vol.286, issue.3, pp.370-375, 2004. ,
Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice, Metabolism, vol.63, issue.1, pp.104-111, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01859366
?-Cell Failure in Diabetes and Preservation by Clinical Treatment, Endocr Rev, vol.28, issue.2, pp.187-218, 2007. ,
Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes, Diabetes, vol.53, pp.16-21, 2004. ,
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat Rev Endocrinol, vol.8, issue.4, pp.228-236, 2012. ,
Hormonal regulation of hepatic glucose production in health and disease, Cell Metab, vol.14, issue.1, pp.9-19, 2011. ,
Non-alcoholic fatty liver disease and diabetes, Metabolism, vol.65, issue.8, pp.1096-1108, 2016. ,
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes Study Investigators, vol.34, issue.2, pp.1139-1144, 2011. ,
Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein, Nat Commun, vol.9, issue.1, p.30, 2018. ,
Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, highcarbohydrate isoenergetic diets, Am J Clin Nutr, vol.77, issue.1, pp.43-50, 2003. ,
Sweet Sixteenth for ChREBP: Established Roles and Future Goals, Cell Metab, vol.26, issue.2, pp.324-341, 2017. ,
Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, vol.114, issue.2, pp.147-152, 2004. ,
Transcriptional regulation of hepatic lipogenesis, Nat Rev Mol Cell Biol, vol.16, issue.11, pp.678-689, 2015. ,
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J Clin Invest, vol.118, issue.3, pp.829-838, 2008. ,
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics, Genet Med Off J Am Coll Med Genet, vol.16, issue.11, p.1, 2014. ,
Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a, Ann Hum Genet, vol.63, issue.2, pp.358-360, 1996. ,
Disturbed lipid metabolism in glycogen storage disease type 1, Eur J Pediatr, vol.161, issue.1, pp.65-69, 2014. ,
Activation of glycolysis and apoptosis in glycogen storage disease type Ia, Mol Genet Metab, vol.97, issue.4, pp.267-271, 2009. ,
Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a, Pediatr Res, vol.63, issue.6, pp.702-707, 2008. ,
Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation, Histochem Cell Biol, vol.127, issue.5, pp.555-565, 2007. ,
, Cell Stress, vol.3, issue.3, 2019.
Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment, J Inborn Errors Metab Screen, vol.4, p.2326409816679429, 2016. ,
Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia, J Hepatol, vol.69, issue.5, pp.1074-1087, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339527
Hepatic glucose-6-phosphatase-? deficiency leads to metabolic reprogramming in glycogen storage disease type Ia, Biochem Biophys Res Commun, vol.498, issue.4, pp.925-931, 2018. ,
Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders, Diabetes Metab, vol.39, issue.5, pp.377-387, 2013. ,
Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation, Nutr Res, vol.36, issue.11, pp.1255-1268, 2016. ,
Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondriadependent pathways: Prophylactic role of arjunolic acid, Free Radic Biol Med, vol.48, issue.11, pp.1465-1484, 2010. ,
Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease, Free Radic Res, vol.49, issue.12, pp.1405-1418, 2015. ,
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis, 2017. ,
, Antioxid Redox Signal, vol.26, issue.10, pp.519-541
Mechanisms of diabetic complications, Physiol Rev, vol.93, issue.1, pp.137-188, 2013. ,
Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions, J Cell Biochem, vol.120, issue.2, pp.2159-2170, 2018. ,
Oxidative stress and autophagy: the clash between damage and metabolic needs, Cell Death Differ, vol.22, issue.3, pp.377-388, 2015. ,
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver, J Clin Invest, vol.125, issue.12, pp.4447-4462, 2015. ,
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies, Trends Endocrinol Metab TEM, vol.28, issue.4, pp.250-260, 2017. ,
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient, Exp Diabetes Res, p.61038, 2007. ,
Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, Toxicol Appl Pharmacol, vol.212, issue.2, pp.167-178, 2006. ,
AGE restriction in diabetes mellitus: a paradigm shift, Nat Rev Endocrinol, vol.7, issue.9, pp.526-539, 2011. ,
The liver is the main site for metabolism of circulating advanced glycation end products, J Hepatol, vol.36, issue.1, pp.123-125, 2002. ,
Advanced glycation endproducts--role in pathology of diabetic complications, Diabetes Res Clin Pract, vol.67, issue.1, pp.3-21, 2005. ,
Hexosamines, insulin resistance and the complications of diabetes: current status, Am J Physiol Endocrinol Metab, vol.290, issue.1, pp.1-8, 2006. ,
Role of the hexosamine biosynthetic pathway in diabetic nephropathy, Kidney Int Suppl, vol.77, pp.1-13, 2000. ,
Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies, Clin Exp Hypertens, vol.26, issue.1, pp.43-53, 2004. ,
Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine, Pharm Biol, vol.50, issue.8, pp.1007-1012, 2012. ,
Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies, Mass Spectrom Rev, vol.33, issue.2, pp.79-97, 2014. ,
DNA damage by reactive species: Mechanisms, mutation and repair, J Biosci, vol.37, issue.3, pp.503-517, 2012. ,
Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer, Chin Med J, vol.128, issue.11, pp.1543-1548, 2015. ,
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes, Diabetes Care, vol.34, issue.2, pp.448-453, 2011. ,
A systematic survey of lipids across mouse tissues, Am J Physiol-Endocrinol Metab, vol.306, issue.8, 2014. ,
Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets, J Biol Chem, vol.266, issue.17, pp.11341-11346, 1991. ,
, , 2017.
, Lipid droplets and liver disease: from basic biology to clinical implications, Nat Rev Gastroenterol Hepatol, vol.14, issue.6, pp.343-355
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatol Baltim Md, vol.45, issue.6, pp.1366-1374, 2007. ,
Lipotoxicity in Nonalcoholic Fatty Liver Disease: Not All Lipids Are Created Equal, Expert Rev Gastroenterol Hepatol, vol.3, issue.4, pp.445-451, 2009. ,
, Cell Stress, vol.3, issue.3, 2019.
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease, Liver Int, 2018. ,
Diacylglycerol-mediated insulin resistance, Nat Med, vol.16, issue.4, pp.400-402, 2010. ,
Role of ceramide in diabetes mellitus: evidence and mechanisms, Lipids Health Dis, vol.12, p.98, 2013. ,
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis, Hepatol Baltim Md, vol.27, issue.1, pp.128-133, 1998. ,
The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts, Redox Biol, vol.3, pp.56-62, 2014. ,
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity, Nature, vol.473, issue.7348, pp.528-531, 2011. ,
Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model, PLoS ONE, vol.7, issue.12, 2012. ,
The role of ER stress in lipid metabolism and lipotoxicity, J Lipid Res, vol.57, issue.8, pp.1329-1338, 2016. ,
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c, Cicho?-Lach H, and Michalak A, vol.12, pp.8082-8091, 2010. ,
Mechanisms of Diabetes-Induced Liver Damage. Sultan Qaboos, Univ Med J, vol.16, issue.2, pp.132-141, 2016. ,
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences, J Hepatol, vol.47, issue.1, pp.142-156, 2007. ,
Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes, Clin Chim Acta Int J Clin Chem, vol.413, pp.1163-1170, 2012. ,
Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus, Mol Immunol, vol.48, pp.1397-1407, 2011. ,
, , 2013.
, an inflammatory process: Oxidative Stress and TNF-alpha involved in hepatic complication, J Biomed Sci Eng, vol.06, issue.06, p.645
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice, Diabetes, vol.52, issue.11, pp.2784-2789, 2003. ,
IL-6 pathway in the liver: From physiopathology to therapy, J Hepatol, vol.64, issue.6, pp.1403-1415, 2016. ,
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action, Cell Metab, vol.12, issue.3, pp.237-249, 2010. ,
Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?, Gastroenterology, vol.150, issue.8, pp.1704-1709, 2016. ,
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease, Hepatol Baltim Md, vol.59, issue.4, pp.1393-1405, 2014. ,
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis, Nature, vol.531, issue.7593, pp.253-257, 2016. ,
Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK, Free Radic Biol Med, vol.47, issue.10, pp.1486-1493, 2009. ,
Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?, J Inherit Metab Dis, 2018. ,
Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse, Nat Genet, vol.13, issue.2, pp.203-209, 1996. ,
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J Hepatol, vol.54, issue.3, pp.529-537, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00575314
Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice, Diabetes, vol.60, issue.12, pp.3121-3131, 2011. ,
Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa), Sci Rep, vol.7, p.44408, 2017. ,
Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia, J Inherit Metab Dis, 2018. ,
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia, Free Radic Biol Med, vol.33, issue.1, pp.103-110, 2002. ,
A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III, Nutr Metab Cardiovasc Dis, vol.19, issue.6, pp.383-390, 2009. ,
Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques, J Inherit Metab Dis, vol.32, issue.5, p.651, 2009. ,
URIC ACID: THE OXIDANT-ANTIOXIDANT PARADOX, Nucleosides Nucleotides Nucleic Acids, vol.27, issue.6, pp.608-619, 2008. ,
A link between hepatic glucose production and peripheral energy metabolism via hepatokines, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01350728
, Mol Metab, vol.3, issue.5, pp.531-543
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context, Mol Metab, vol.16, pp.100-115, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339561
Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency, J Hepatol, vol.64, issue.2, pp.370-379, 2016. ,
Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia, PLOS Genet, vol.13, issue.5, p.1006819, 2017. ,
Role of autophagy in cancer, Nat Rev Cancer, vol.7, issue.12, pp.961-967, 2007. ,
Autophagy and the integrated stress response, Mol Cell, vol.40, issue.2, pp.280-293, 2010. ,
Autophagy Dysregulation and Obesity-Associated Pathologies, Mol Cells, vol.41, issue.1, pp.3-10, 2018. ,
S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy, Diabetes, vol.67, issue.2, pp.193-207, 2018. ,
Autophagy and non-alcoholic fatty liver disease, BioMed Res Int, p.120179, 2014. ,
Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in Hepatocytes, J Pharmacol Exp Ther, vol.339, issue.2, pp.487-498, 2011. ,
Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia, J Hepatol, vol.48, issue.3, pp.479-485, 2008. ,
Diabetes and Chronic Liver Disease: Etiology and Pitfalls in Monitoring, Clin Diabetes, vol.28, issue.4, pp.139-144, 2010. ,
Diabetes mellitus and metformin in hepatocellular carcinoma, World J Gastroenterol, vol.22, issue.27, pp.6100-6113, 2016. ,
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis, Diabetes Metab Res Rev, vol.28, issue.2, pp.109-122, 2012. ,
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis, Am J Gastroenterol, vol.111, issue.11, pp.1573-1580, 2016. ,
Diabetes and cancer: a consensus report, CA Cancer J Clin, vol.60, issue.4, pp.207-221, 2010. ,
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma, Liver Int Off J Int Assoc Study Liver, vol.35, issue.10, pp.2203-2217, 2015. ,
Glucose-induced ?-catenin acetylation enhances Wnt signaling in cancer, Mol Cell, vol.49, issue.3, pp.474-486, 2013. ,
, The role of adipokines in liver fibrosis, Pathophysiol Off J Int Soc Pathophysiol, vol.15, issue.2, pp.91-101, 2008.
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, Hepatol Baltim Md, vol.34, issue.6, pp.125-172, 2001. ,
Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver, Curr Pathobiol Rep, vol.3, issue.4, pp.243-252, 2015. ,
The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey), Hepatol Baltim Md, vol.20, pp.1061-1077, 1994. ,
Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management, World J Gastroenterol, vol.15, issue.3, pp.280-288, 2009. ,
Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study, Oncotarget, vol.8, issue.46, pp.81321-81328, 2017. ,
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention, J Clin Transl Hepatol, vol.1, issue.2, pp.131-137, 2013. ,
The Natural Course of Non-Alcoholic Fatty Liver Disease, Int J Mol Sci, vol.17, issue.5, 2016. ,
Population-based risk factors and resource utilization for HCC: US perspective, Curr Med Res Opin, vol.26, issue.9, pp.2183-2191, 2010. ,
NAT-URAL HISTORY OF HEPATOCELLULAR ADENOMA FORMATION IN GLY-COGEN STORAGE DISEASE TYPE I, J Pediatr, vol.159, issue.3, pp.442-446, 2011. ,
Functional Relationships between Lipid Metabolism and Liver Regeneration, Int J Hepatol, p.549241, 2012. ,
Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration, 2016. ,
, Am J Pathol, vol.186, issue.3, pp.587-599
Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review, Nutrition, vol.15, issue.10, pp.784-788, 1999. ,
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy, World J Hepatol, vol.7, issue.3, pp.593-599, 2015. ,
Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?, World J Hepatol, vol.7, issue.7, pp.968-979, 2015. ,
Ten misconceptions about antioxidants, Trends Pharmacol Sci, vol.34, issue.8, pp.430-436, 2013. ,
Paradoxical effects of antioxidants on cancer, Rejuvenation Res, vol.17, issue.3, pp.306-311, 2014. ,
Cancer cell killing via ROS: to increase or decrease, that is the question, Cancer Biol Ther, vol.7, issue.12, pp.1875-1884, 2008. ,